Title: Pharmacokinetics and Pharmacodynamics of Edoxaban, a Non-Vitamin K Antagonist Oral Anticoagulant that Inhibits Clotting Factor Xa.
Journal: Clinical pharmacokinetics20160101
Title: Overview of the new oral anticoagulants: opportunities and challenges.
Journal: Arteriosclerosis, thrombosis, and vascular biology20150501
Title: The role of factor Xa inhibitors in venous thromboembolism treatment.
Journal: Vascular health and risk management20150101
Title: Characterisation of exposure versus response of edoxaban in patients undergoing total hip replacement surgery.
Journal: Thrombosis and haemostasis20121101
Title: Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing20121001
Title: Oral direct factor Xa inhibitors.
Journal: Circulation research20120928
Title: Comparison of antithrombotic and haemorrhagic effects of edoxaban, an oral direct factor Xa inhibitor, with warfarin and enoxaparin in rats.
Journal: Thrombosis research20120901
Title: The promise of novel direct oral anticoagulants.
Journal: Best practice & research. Clinical haematology20120901
Title: Edoxaban administration following enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects.
Journal: Thrombosis and haemostasis20120701
Title: Long-term benefits of preventing venous thromboembolic events.
Journal: Current medical research and opinion20120601
Title: Current and future alternatives to warfarin for the prevention of stroke in atrial fibrillation.
Journal: Critical pathways in cardiology20120601
Title: In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.
Journal: Thrombosis research20120401
Title: Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation.
Journal: Circulation journal : official journal of the Japanese Circulation Society20120101
Title: Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates.
Journal: Thrombosis and haemostasis20111201
Title: Antithrombin-independent thrombin inhibitors, but not direct factor Xa inhibitors, enhance thrombin generation in plasma through inhibition of thrombin-thrombomodulin-protein C system.
Journal: Thrombosis and haemostasis20111201
Title: [Current status and future of anti-Xa inhibitors].
Journal: Rinsho shinkeigaku = Clinical neurology20111101
Title: The new oral anticoagulants.
Journal: Clinical medicine (London, England)20111001
Title: Edoxaban for the prevention of thromboembolic events after surgery.
Journal: Drugs of today (Barcelona, Spain : 1998)20111001
Title: [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Journal: Giornale italiano di cardiologia (2006)20110901
Title: Edoxaban: a new oral direct factor xa inhibitor.
Journal: Drugs20110820
Title: Edoxaban: pharmacological principles, preclinical and early-phase clinical testing.
Journal: Future cardiology20110701
Title: [New anticoagulants in the prevention and treatment of venous thromboembolism].
Journal: Orvosi hetilap20110619
Title: Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux.
Journal: Thrombosis and haemostasis20110601
Title: Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation.
Journal: Thrombosis and haemostasis20110301
Title: Factor Xa and thrombin as targets for new oral anticoagulants.
Journal: Thrombosis research20110101
Title: Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
Journal: Annual review of medicine20110101
Title: Edoxaban tosylate.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions20110101
Title: A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty.
Journal: Journal of thrombosis and haemostasis : JTH20101101
Title: Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adults.
Journal: Thrombosis research20101001
Title: Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
Journal: American heart journal20101001
Title: Oral direct factor Xa inhibition with edoxaban for thromboprophylaxis after elective total hip replacement. A randomised double-blind dose-response study.
Journal: Thrombosis and haemostasis20100901
Title: Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation.
Journal: Thrombosis and haemostasis20100901
Title: [Do orally active factor Xa (FXa) inhibitors have potential as innovative new anticoagulants? Future perspective from preclinical data].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20100801
Title: Clinical safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel factor Xa inhibitor edoxaban in healthy volunteers.
Journal: Journal of clinical pharmacology20100701
Title: Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.
Journal: Current opinion in cardiology20100701
Title: New anticoagulants for atrial fibrillation.
Journal: Seminars in thrombosis and hemostasis20090701
Title: DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles.
Journal: Journal of thrombosis and haemostasis : JTH20080901
